Ashwagandha and Blood Sugar: What the Research Shows

Ashwagandha and Blood Sugar is a topic worth examining carefully because stress, sleep, activity, and glucose regulation are closely connected. Ashwagandha may affect some of those upstream factors, but the human studies provided here did not directly test whether it lowers fasting glucose, HbA1c, insulin resistance, or diabetes risk.

The Evidence Base: What These Studies Actually Show

The available evidence is strongest for ashwagandha’s effects on stress-related symptoms, anxiety, sleep, physical training outcomes, and selected cognitive measures. The provided studies include randomized, double-blind, placebo-controlled human trials, plus a systematic review of human anxiety trials. That is useful clinical evidence, but it is not the same as evidence for blood-sugar management.

Chandrasekhar et al. (2012) studied adults with chronic stress using a high-concentration full-spectrum ashwagandha root extract. Participants receiving ashwagandha reported improved stress and anxiety measures compared with placebo. The study also reported lower serum cortisol in the ashwagandha group, which matters because cortisol can influence glucose metabolism.

However, a reduction in cortisol does not establish that ashwagandha improves blood sugar. Cortisol is one part of a larger metabolic system involving liver glucose output, insulin secretion, muscle glucose uptake, sleep, diet, body composition, medications, and underlying disease. Without direct glucose-related outcomes, any claim about glycemic benefit would go beyond the study’s findings.

Langade et al. (2019) examined ashwagandha root extract in adults with insomnia and anxiety. The trial found improvements in sleep-related outcomes and anxiety measures. Sleep quality is relevant to metabolic health, but the study was not designed to determine whether ashwagandha changes blood glucose or improves insulin sensitivity.

Wankhede et al. (2015) studied ashwagandha supplementation alongside resistance training in healthy men. The ashwagandha group showed favorable changes in strength, muscle size, recovery-related measures, and testosterone compared with placebo. Muscle tissue is a major site of glucose disposal after meals, but this trial did not measure glucose control or establish an antidiabetic effect.

Choudhary et al. (2017) evaluated ashwagandha root extract for memory and cognitive function in adults with mild cognitive impairment. The study reported improvements in several cognitive measures. These findings may be relevant for people interested in stress resilience or mental performance, but they do not answer whether ashwagandha changes blood sugar.

Pratte et al. (2014) reviewed human trials of ashwagandha for anxiety. The review concluded that the herb showed potential for anxiety reduction, while also noting limitations in the available evidence. A systematic review can summarize a research area, but it cannot create direct blood-sugar evidence where the underlying studies did not measure glucose outcomes.

Study	Population and design	Ashwagandha approach	Outcomes reported	Direct blood-sugar evidence?
Chandrasekhar et al. (2012)	Adults with chronic stress; randomized, double-blind, placebo-controlled trial	High-concentration full-spectrum root extract, 300 mg twice daily	Stress, anxiety, cortisol, safety	Limited data: glucose outcomes were not the stated focus
Langade et al. (2019)	Adults with insomnia and anxiety; randomized, double-blind, placebo-controlled trial	Root extract, 300 mg twice daily	Sleep and anxiety outcomes	Limited data: no direct glycemic outcome reported
Wankhede et al. (2015)	Healthy men undertaking resistance training; randomized, double-blind, placebo-controlled trial	Root extract, 300 mg twice daily	Strength, muscle size, recovery-related measures	Limited data: no direct glycemic outcome reported
Choudhary et al. (2017)	Adults with mild cognitive impairment; randomized, double-blind, placebo-controlled trial	Root extract, 300 mg twice daily	Memory and cognitive function	Limited data: no direct glycemic outcome reported
Pratte et al. (2014)	Systematic review of human anxiety trials	Varied across included trials	Anxiety-related outcomes and study limitations	Not a direct review of blood-sugar outcomes

The Mechanism: Why Stress Could Matter for Glucose

Ashwagandha is commonly described as an adaptogen, a term generally used for substances proposed to influence the body’s response to stress. In practical biochemical terms, the relevant question is whether ashwagandha meaningfully changes stress signaling in humans. Chandrasekhar et al. (2012) provides the most relevant evidence among the supplied studies because it reported changes in cortisol alongside improvements in perceived stress.

Cortisol is a glucocorticoid hormone released through the hypothalamic-pituitary-adrenal axis. During acute stress, cortisol helps ensure that fuel is available by supporting processes that increase circulating glucose. This response is normal and useful when temporary; the issue is persistent elevation or dysregulation in the context of poor sleep, inactivity, excess energy intake, illness, or insulin resistance.

The liver is central to this process. Cortisol can support hepatic glucose production, meaning the liver releases glucose into the bloodstream. In a person with normal metabolic flexibility, insulin and other signals help bring glucose back toward the individual’s usual range after food intake or stress exposure.

In insulin resistance, that coordination can become less efficient. Muscle and other tissues may respond less effectively to insulin, while the liver may continue producing glucose when it is not needed. This is why chronic stress can be relevant to metabolic health without being the sole cause of elevated blood sugar.

Ashwagandha could therefore have an indirect relationship with blood sugar if it helps some people manage stress or sleep more effectively. That possibility is biologically plausible, but plausibility is not proof. The provided trials do not show whether observed improvements in stress or sleep translated into lower fasting glucose, better post-meal glucose handling, lower insulin levels, or clinically meaningful changes in HbA1c.

Sleep is another plausible pathway. Poor sleep and fragmented sleep can affect appetite regulation, activity patterns, stress hormones, and insulin signaling. Langade et al. (2019) found that ashwagandha root extract improved sleep-related outcomes in a population with insomnia and anxiety, but no glucose measures were provided.

Physical activity provides a third indirect pathway. Contracting skeletal muscle can take up glucose, and resistance training can support muscle mass and metabolic health. Wankhede et al. (2015) found beneficial training-related outcomes with ashwagandha supplementation, but the study does not allow us to conclude that the supplement independently improved glucose handling.

What the Evidence Does Not Show

It is important to separate an effect on stress from an effect on diabetes or prediabetes. A supplement can improve a subjective outcome, such as perceived stress, without producing a measurable change in fasting blood glucose or HbA1c. Conversely, someone may have improved blood sugar through diet, medication, weight change, or exercise without noticing a major change in stress.

The supplied research does not establish that ashwagandha prevents type 2 diabetes. It also does not establish that it treats diabetes, replaces glucose-lowering medication, reduces insulin requirements, or protects against diabetes complications. Those are clinical claims that require trials measuring those exact outcomes in relevant populations.

There is also no basis in these studies for assigning a specific blood-sugar dose. The repeated 300 mg twice-daily regimen is a feature of several provided trials, but those trials targeted stress, sleep, cognition, or training outcomes. Translating that dose into a recommendation for glycemic control would be inappropriate.

Product form matters, too. The studies here used root extracts, including high-concentration full-spectrum root extract in Chandrasekhar et al. (2012). “Ashwagandha” is not a single standardized intervention: extracts can differ in plant part, extraction process, constituent profile, and dose. Research on one preparation should not automatically be generalized to every powder, capsule, blend, or tincture.

Interpreting Cortisol Findings Without Overreaching

Cortisol is often discussed as though lower is always better. That is inaccurate. Cortisol has essential roles in normal waking, immune regulation, blood-pressure maintenance, energy availability, and responses to physical and psychological stress.

The more useful goal is not to suppress cortisol indiscriminately. It is to support an appropriate stress response and healthy day-to-day regulation. A person with a demanding job, disrupted sleep, under-fueling, excessive training, or poorly managed anxiety may have several reasons to address stress, but a supplement is only one possible component.

Chandrasekhar et al. (2012) supports the idea that a studied ashwagandha extract may influence cortisol in stressed adults. It does not show that cortisol reduction is the mechanism behind every reported benefit, nor does it prove a downstream glucose benefit. Mechanistic stories should remain proportional to the actual measurements.

Individual response also matters. Some people may experience a noticeable improvement in stress perception or sleep, while others may not. Even if stress improves, the effect on eating patterns, exercise consistency, alcohol intake, glucose monitoring, or medication adherence can vary substantially from person to person.

Practical Application: Where Ashwagandha May Fit

For an adult interested in metabolic health, the highest-value interventions remain the ones directly tied to glucose regulation: an eating pattern that supports individual needs, regular physical activity, adequate sleep, appropriate medical care, and prescribed medication when indicated. Ashwagandha should not be positioned as a shortcut around these fundamentals. The available evidence supports a more modest role centered on stress and sleep-related concerns.

If stress or poor sleep is interfering with consistent health behaviors, an ashwagandha root extract may be worth discussing with a qualified clinician or pharmacist. The rationale would be support for those symptoms based on the provided trials, not a claim that the product is a verified glucose-lowering treatment. This distinction is especially important for people already monitoring glucose or using medication.

When selecting a supplement, use the exact study context as a guide rather than assuming that all forms are interchangeable. Look for clear labeling of the botanical source, plant part, extract identity, and amount per serving. A product such as Bio:sudo KSM-66 Reishi Restore may fit a broader stress-support routine, but its inclusion does not convert the current evidence into direct proof of blood-sugar benefit.

It is also sensible to evaluate one change at a time. Starting several supplements, changing diet, beginning a workout program, and altering medication use simultaneously makes it difficult to understand what is helping or causing side effects. For people with diabetes or prediabetes, glucose readings and clinician-guided laboratory measures are more informative than relying on subjective impressions alone.

Safety and Medication Considerations

The provided trials reported safety outcomes within their study periods, but short clinical trials cannot answer every safety question for every person. “Natural” does not mean risk-free, particularly for people with medical conditions, people who are pregnant or breastfeeding, or those using prescription medications. Product quality and the specific extract used also matter.

People taking glucose-lowering medication should be particularly careful with any supplement marketed for metabolic support. Even though the sources provided here do not establish a direct glucose-lowering effect for ashwagandha, medication plans should not be changed based on supplement expectations. A clinician can help assess potential risks in the context of actual glucose data, diagnosis, and other medications.

People with ongoing insomnia, anxiety, unexplained fatigue, frequent urination, unusual thirst, or unintentional weight change should not self-treat these symptoms as a supplement problem. These symptoms can have many causes, including conditions that require medical assessment. Ashwagandha may be a reasonable topic for a conversation, but it is not a substitute for diagnosis.

Who Benefits Most

Based on the supplied research, the evidence is strongest for adults with stress, anxiety symptoms, or sleep difficulty, rather than for people seeking a direct blood-sugar intervention. Chandrasekhar et al. (2012) studied chronically stressed adults, and Langade et al. (2019) studied adults with insomnia and anxiety. These are the populations most closely aligned with the reported outcomes.

Healthy adults engaged in resistance training are another group with relevant, though different, evidence. Wankhede et al. (2015) reported favorable strength and recovery-related outcomes in men undertaking a resistance-training program. This may matter for people building sustainable exercise habits, but it should not be presented as proof of improved insulin sensitivity or diabetes treatment.

Adults with mild cognitive impairment were studied by Choudhary et al. (2017), with improvements reported in cognitive measures. That result may be relevant for people considering ashwagandha for cognitive concerns, but it does not identify a population that benefits most for blood sugar. Direct glycemic research would need to enroll people with prediabetes, diabetes, or measured insulin resistance and assess clinically relevant metabolic endpoints.

Practical Takeaways

• The provided studies do not directly show that ashwagandha lowers blood sugar, HbA1c, insulin levels, or diabetes risk.
• Human trials support potential benefits for stress, anxiety-related symptoms, sleep, selected cognitive outcomes, and training-related outcomes in the studied populations.
• Lower cortisol reported by Chandrasekhar et al. (2012) offers a plausible indirect connection to metabolic health, but it is not proof of glycemic improvement.
• The commonly studied 300 mg twice-daily root-extract regimen should not be interpreted as a validated dose for blood-sugar control.
• For diabetes or prediabetes, use glucose monitoring, clinician-guided care, food habits, physical activity, sleep, and prescribed medication as the foundation.
• Discuss supplement use with a clinician or pharmacist if you take medication, have a chronic condition, or are considering ashwagandha for symptoms that may need evaluation.

Bottom Line

Ashwagandha has human evidence for stress, anxiety, sleep, and certain other outcomes, and those factors can intersect with metabolic health. But based on the studies provided, evidence for Ashwagandha and Blood Sugar remains indirect and limited: there is no direct clinical basis to call it a glucose-lowering or diabetes-treatment supplement. The most accurate conclusion is that ashwagandha may support stress-related goals for some adults, while blood-sugar claims require dedicated human research.

References

1. Chandrasekhar K, et al. "A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults." Indian Journal of Psychological Medicine. 2012;34(3):255–262. [Source]
2. Langade D, et al. "Efficacy and safety of ashwagandha (Withania somnifera) root extract in insomnia and anxiety." Medicine. 2019;98(37):e17186. [Source]
3. Wankhede S, et al. "Examining the effect of Withania somnifera supplementation on muscle strength and recovery." Journal of the International Society of Sports Nutrition. 2015;12:43. [Source]
4. Choudhary D, et al. "Efficacy and safety of ashwagandha (Withania somnifera) root extract in improving memory and cognitive functions." Journal of Dietary Supplements. 2017;14(6):599–612. [Source]
5. Pratte MA, et al. "An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha." Journal of Alternative and Complementary Medicine. 2014;20(12):901–908. [Source]

---

---